Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,020 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
Ridker PM, Stampfer MJ, Rifai N. Ridker PM, et al. JAMA. 2001 May 16;285(19):2481-5. doi: 10.1001/jama.285.19.2481. JAMA. 2001. PMID: 11368701
Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.
Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Shen C, Newcomer LM, Goldhaber SZ, Hennekens CH. Ridker PM, et al. Circulation. 1992 May;85(5):1822-7. doi: 10.1161/01.cir.85.5.1822. Circulation. 1992. PMID: 1572039
The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study.
Ridker PM, Manson JE, Buring JE, Goldhaber SZ, Hennekens CH. Ridker PM, et al. Am Heart J. 1991 Dec;122(6):1588-92. doi: 10.1016/0002-8703(91)90275-m. Am Heart J. 1991. PMID: 1957753 Clinical Trial.
Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.
Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekens CH. Ridker PM, et al. Circulation. 1995 Nov 15;92(10):2800-2. doi: 10.1161/01.cir.92.10.2800. Circulation. 1995. PMID: 7586244
Plasma concentration of lipoprotein(a) and the risk of future stroke.
Ridker PM, Stampfer MJ, Hennekens CH. Ridker PM, et al. JAMA. 1995 Apr 26;273(16):1269-73. JAMA. 1995. PMID: 7715039
Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation.
Gaziano JM, Hatta A, Flynn M, Johnson EJ, Krinsky NI, Ridker PM, Hennekens CH, Frei B. Gaziano JM, et al. Among authors: ridker pm. Atherosclerosis. 1995 Jan 20;112(2):187-95. doi: 10.1016/0021-9150(94)05414-e. Atherosclerosis. 1995. PMID: 7772078 Clinical Trial.
Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator.
Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Ridker PM, et al. JAMA. 1994 Sep 28;272(12):929-33. doi: 10.1001/jama.1994.03520120039028. JAMA. 1994. PMID: 7794308
Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.
Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Ridker PM, et al. N Engl J Med. 1995 Apr 6;332(14):912-7. doi: 10.1056/NEJM199504063321403. N Engl J Med. 1995. PMID: 7877648
Prospective study of endogenous tissue plasminogen activator and risk of stroke.
Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Ridker PM, et al. Lancet. 1994 Apr 16;343(8903):940-3. doi: 10.1016/s0140-6736(94)90064-7. Lancet. 1994. PMID: 7909008
Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.
Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Ridker PM, et al. Circulation. 1994 Nov;90(5):2236-40. doi: 10.1161/01.cir.90.5.2236. Circulation. 1994. PMID: 7955179
1,020 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback